cerrar
Tagged with

Cannabinoid Drugs, Medicinal Cannabis and Opioid Drugs: Canada
The legal framework for cannabinoid drugs, medical cannabis and opioids in Canada. Prepared in association with Fasken, a leading global law firm,…

Regulatory Reform: Canada
An insight into upcoming regulatory reforms affecting Canadian pharma. Prepared in association with Fasken, a leading global law firm, this is an…

Patents & Trademarks: Canada
The low-down on the situation regarding patents and trademarks in Canadian pharma. Prepared in association with Fasken, a leading global law firm,…

Product Liability: Canada
All about product liability in Canadian pharma. Prepared in association with Fasken, a leading global law firm, this is an extract from The Pharma…

Traditional Medicines and OTC Products: Canada
An intro to the legal situation for traditional products and OTC medicines in Canada. Prepared in association with Fasken, a leading global law…

Marketing, Manufacturing, Packaging & Labeling, Advertising:…
The ins and outs of the marketing, manufacturing, packaging & labeling, and advertising in Canadian pharma. Prepared in association with Fasken, a…

Preclinical and Clinical Trial Requirements: Canada
Preclinical and clinical trial requirements for pharma in Canada - a comprehensive legal overview. Prepared in association with Fasken, a leading…

Regulatory, Pricing and Reimbursement: Canada
A brief overview of the situation regarding regulation, pricing and reimbursement of drugs in Canada. Prepared in association with Fasken, a leading…

AstraZeneca’s EUR 135 Million Investment in France
On January 21st, 2019, AstraZeneca inaugurated the extension of the group’s industrial site in the city of Dunkirk in Northern France. The launch…

Egypt’s Hep C ‘Tour n’ Cure’ –…
Egypt has found a way to profit from the country's access to cheap Hep C drugs by offering package holidays to tourists suffering from the disease,…

Egypt: Tackling Hep C
With the highest rate of Hepatitis C on the planet, Egypt is now making great efforts to eradicate the disease in the north MENA regions. Hep C is a…

Korean Healthcare and Pharma’s 10-Year Plan
The administration of President Moon Jae-in is moving to ensure the enduring success of South Korea’s healthcare and life sciences industries…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here